ACADIA Pharmaceuticals Inc.

NASDAQ:ACAD

17.66 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Revenue 726.437517.235484.145441.755339.076223.807124.90117.3310.0610.121.1454.9072.06742.1356.3991.597.5558.13310.9564.6047.3786.2763.7144.312
Cost of Revenue 45.73110.16619.14120.5519.59818.3313.064.40676.36960.60226.72218.794000000000000
Gross Profit 680.706507.069465.004421.205319.478205.477111.84112.925-76.308-60.482-25.577-13.8872.06742.1356.3991.597.5558.13310.9564.6047.3786.2763.7144.312
Gross Profit Ratio 0.9370.980.960.9530.9420.9180.8950.746-1,250.951-504.017-22.338-2.83111111111111
Reseach & Development Expenses 351.619361.575239.415319.13240.385187.163149.18999.28473.86960.60226.72218.79417.30920.57941.58556.7557.94249.39830.84823.45416.93514.92113.099.728
General & Administrative Expenses 393.066363.59396.028388.661325.638265.758255.062186.45690.80432.74812.726.9997.616.46210.28211.81812.26711.34915.9157.2464.1833.9813.7562.999
Selling & Marketing Expenses 9.45.541.851.138.339.815.61.60000000000000000
SG&A 402.466369.09396.028388.661325.638265.758255.062186.45690.80432.74812.726.9997.616.46210.28211.81812.26711.34915.9157.2464.1833.9813.7562.999
Other Expenses 5.1093.5422.329-0.9970.997-1.843.9831.3312.500000000-3.567.5282.356002.1472.854
Operating Expenses 754.085730.665635.443707.791566.023452.921404.251285.74164.67393.3539.44225.79324.91927.04151.86768.56870.20957.18746.76330.721.11818.90218.99315.581
Operating Income -73.379-223.596-170.439-286.586-246.545-247.444-292.41-272.815-164.612-93.23-38.297-20.886-22.85215.094-45.468-66.978-62.654-49.054-35.806-26.095-13.74-12.626-15.279-11.269
Operating Income Ratio -0.101-0.432-0.352-0.649-0.727-1.106-2.341-15.741-2,698.557-776.917-33.447-4.256-11.0560.358-7.105-42.125-8.293-6.031-3.268-5.668-1.862-2.012-4.114-2.613
Total Other Income Expenses Net 22.34310.1522.925.61312.162-1.844.1262.7630.4990.7550.3490.0370.0870.0450.3232.7346.2643.561.6710.1780000
Income Before Tax -51.036-213.444-167.519-280.973-234.383-243.936-288.284-270.052-164.113-92.475-37.948-20.849-22.76515.139-45.145-64.244-56.39-45.048-34.135-25.9170000
Income Before Tax Ratio -0.07-0.413-0.346-0.636-0.691-1.09-2.308-15.582-2,690.377-770.625-33.142-4.249-11.0140.359-7.055-40.405-7.464-5.539-3.116-5.6290000
Income Tax Expense 10.252.5310.3510.6110.8761.2561.1191.3410.33-0.2060-0.109000-1.0430-3.86-0-00.3530.24214.40610.194
Net Income -61.286-215.975-167.87-281.584-235.259-245.192-289.403-271.393-164.443-92.475-37.948-20.849-22.76515.139-45.145-64.244-56.39-45.048-34.135-25.917-14.093-12.868-14.406-10.194
Net Income Ratio -0.084-0.418-0.347-0.637-0.694-1.096-2.317-15.659-2,695.787-770.625-33.142-4.249-11.0140.359-7.055-40.405-7.464-5.539-3.116-5.629-1.91-2.051-3.879-2.364
EPS -0.37-1.34-1.05-1.79-1.6-1.94-2.36-2.34-1.63-0.95-0.44-0.38-0.440.39-1.2-1.73-1.6-1.61-1.55-2.5-9.66-8.86-11.93-9.53
EPS Diluted -0.37-1.34-1.05-1.79-1.6-1.94-2.36-2.34-1.63-0.95-0.44-0.38-0.440.39-1.2-1.73-1.6-1.61-1.55-2.5-1.24-8.86-11.93-9.53
EBITDA -67.827-223.596-170.439-286.586-246.545-247.444-292.41-272.815-164.612-93.23-38.218-20.886-22.56715.701-44.357-66.978-61.886-52.614-34.781-24.79-12.396-11.223-15.279-11.269
EBITDA Ratio -0.093-0.432-0.352-0.649-0.727-1.106-2.341-15.741-2,698.557-776.917-33.378-4.256-10.9180.373-6.932-42.125-8.191-6.469-3.174-5.384-1.68-1.788-4.114-2.613